
Magdalene K. Sgagias
Examiner (ID: 4537, Phone: (571)272-3305 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 637 |
| Issued Applications | 229 |
| Pending Applications | 42 |
| Abandoned Applications | 366 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4898947
[patent_doc_number] => 20080118561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'Materials and Methods for Minimally-Invasive Administration of a Cell-Containing Flowable Composition'
[patent_app_type] => utility
[patent_app_number] => 11/792284
[patent_app_country] => US
[patent_app_date] => 2005-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18619
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20080118561.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792284
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792284 | Materials and Methods for Minimally-Invasive Administration of a Cell-Containing Flowable Composition | Dec 5, 2005 | Abandoned |
Array
(
[id] => 5487099
[patent_doc_number] => 20090276864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'TRANSGENIC ANIMALS WITH REDUCED MAJOR URINARY PROTEIN PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 11/720730
[patent_app_country] => US
[patent_app_date] => 2005-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14217
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20090276864.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720730
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720730 | TRANSGENIC ANIMALS WITH REDUCED MAJOR URINARY PROTEIN PRODUCTION | Dec 4, 2005 | Abandoned |
Array
(
[id] => 5688950
[patent_doc_number] => 20060287265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Apoptosis-specific eIF-5A and polynucleotides encoding same'
[patent_app_type] => utility
[patent_app_number] => 11/293391
[patent_app_country] => US
[patent_app_date] => 2005-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 177
[patent_figures_cnt] => 177
[patent_no_of_words] => 54160
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287265.pdf
[firstpage_image] =>[orig_patent_app_number] => 11293391
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/293391 | Apoptosis-specific eIF-5A and polynucleotides encoding same | Dec 4, 2005 | Abandoned |
Array
(
[id] => 5615469
[patent_doc_number] => 20060117399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Animal model for human lymphomas'
[patent_app_type] => utility
[patent_app_number] => 11/290192
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6632
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20060117399.pdf
[firstpage_image] =>[orig_patent_app_number] => 11290192
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/290192 | Animal model for human lymphomas | Nov 28, 2005 | Abandoned |
Array
(
[id] => 5289962
[patent_doc_number] => 20090022692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'THERAPEUTIC AGENT FOR HEART DISEASE USING MAP KINASE TNNI3K'
[patent_app_type] => utility
[patent_app_number] => 11/720041
[patent_app_country] => US
[patent_app_date] => 2005-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4174
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022692.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720041
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720041 | THERAPEUTIC AGENT FOR HEART DISEASE USING MAP KINASE TNNI3K | Nov 23, 2005 | Abandoned |
Array
(
[id] => 5517089
[patent_doc_number] => 20090217396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Inflammation models in neurodegenerative and arthritic disorders'
[patent_app_type] => utility
[patent_app_number] => 11/667392
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 54199
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20090217396.pdf
[firstpage_image] =>[orig_patent_app_number] => 11667392
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/667392 | Inflammation models in neurodegenerative and arthritic disorders | Nov 13, 2005 | Abandoned |
Array
(
[id] => 5215612
[patent_doc_number] => 20070104693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Breast augmentation system'
[patent_app_type] => utility
[patent_app_number] => 11/268432
[patent_app_country] => US
[patent_app_date] => 2005-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6864
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20070104693.pdf
[firstpage_image] =>[orig_patent_app_number] => 11268432
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/268432 | Breast augmentation system | Nov 6, 2005 | Abandoned |
Array
(
[id] => 5912420
[patent_doc_number] => 20060127482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Combination of immuno gene therapy & chemotherapy for treatment of cancer & hyperproliferative diseases'
[patent_app_type] => utility
[patent_app_number] => 11/261931
[patent_app_country] => US
[patent_app_date] => 2005-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10655
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127482.pdf
[firstpage_image] =>[orig_patent_app_number] => 11261931
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/261931 | Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases | Oct 27, 2005 | Issued |
Array
(
[id] => 5297572
[patent_doc_number] => 20090012498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Gene therapy for treatment of heart failure'
[patent_app_type] => utility
[patent_app_number] => 11/665007
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5353
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012498.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665007
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665007 | Gene therapy for treatment of heart failure | Oct 26, 2005 | Abandoned |
Array
(
[id] => 6649597
[patent_doc_number] => 20100037329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'Development of sensitive fret sensors and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 11/665339
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17549
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 46
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20100037329.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665339
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665339 | Development of sensitive FRET sensors and methods of using the same | Oct 13, 2005 | Issued |
Array
(
[id] => 5721247
[patent_doc_number] => 20060074022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Prevention of primary Sjogren\'s Syndrome by ICA69 deficiency'
[patent_app_type] => utility
[patent_app_number] => 11/241450
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7859
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074022.pdf
[firstpage_image] =>[orig_patent_app_number] => 11241450
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/241450 | Prevention of primary Sjogren's Syndrome by ICA69 deficiency | Sep 29, 2005 | Abandoned |
Array
(
[id] => 5721267
[patent_doc_number] => 20060074042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Highly hypoxia-specific gene expression system for ischemic gene therapy'
[patent_app_type] => utility
[patent_app_number] => 11/238664
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3892
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074042.pdf
[firstpage_image] =>[orig_patent_app_number] => 11238664
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/238664 | Highly hypoxia-specific gene expression system for ischemic gene therapy | Sep 27, 2005 | Abandoned |
Array
(
[id] => 5728814
[patent_doc_number] => 20060059575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Method for preparing monoclonal antibody'
[patent_app_type] => utility
[patent_app_number] => 11/238983
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8216
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20060059575.pdf
[firstpage_image] =>[orig_patent_app_number] => 11238983
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/238983 | Method for preparing monoclonal antibody | Sep 27, 2005 | Issued |
Array
(
[id] => 5631610
[patent_doc_number] => 20060148080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS'
[patent_app_type] => utility
[patent_app_number] => 11/162715
[patent_app_country] => US
[patent_app_date] => 2005-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19743
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148080.pdf
[firstpage_image] =>[orig_patent_app_number] => 11162715
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/162715 | METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS | Sep 19, 2005 | Abandoned |
Array
(
[id] => 5830892
[patent_doc_number] => 20060064770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Methods for identifying a cell or an embryo carrying a Y chromosome'
[patent_app_type] => utility
[patent_app_number] => 11/227848
[patent_app_country] => US
[patent_app_date] => 2005-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6214
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20060064770.pdf
[firstpage_image] =>[orig_patent_app_number] => 11227848
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/227848 | Methods for identifying a cell or an embryo carrying a Y chromosome | Sep 14, 2005 | Abandoned |
Array
(
[id] => 5777318
[patent_doc_number] => 20060105958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/224532
[patent_app_country] => US
[patent_app_date] => 2005-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14025
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105958.pdf
[firstpage_image] =>[orig_patent_app_number] => 11224532
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/224532 | Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis | Sep 11, 2005 | Abandoned |
Array
(
[id] => 5705271
[patent_doc_number] => 20060194319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Promoter substitution for immunoglobulin therapy'
[patent_app_type] => utility
[patent_app_number] => 11/219347
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12679
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194319.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219347
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219347 | Promoter substitution for immunoglobulin therapy | Sep 1, 2005 | Abandoned |
Array
(
[id] => 4971278
[patent_doc_number] => 20070111280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Compositions and methods for non-targeted activation of endogenous genes'
[patent_app_type] => utility
[patent_app_number] => 11/218378
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 50473
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20070111280.pdf
[firstpage_image] =>[orig_patent_app_number] => 11218378
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/218378 | Compositions and methods for non-targeted activation of endogenous genes | Sep 1, 2005 | Issued |
Array
(
[id] => 4761522
[patent_doc_number] => 20080313748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Transgenic Non-Human Animals Comprising the Human Udp-Glucuronosyltransferase 1A (Ugt1a) Gene Locus and Methods of Using Them'
[patent_app_type] => utility
[patent_app_number] => 11/574671
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17390
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0313/20080313748.pdf
[firstpage_image] =>[orig_patent_app_number] => 11574671
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/574671 | Transgenic Non-Human Animals Comprising the Human Udp-Glucuronosyltransferase 1A (Ugt1a) Gene Locus and Methods of Using Them | Sep 1, 2005 | Abandoned |
Array
(
[id] => 5720345
[patent_doc_number] => 20060073119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Methods for treating neurodegenerative disorders'
[patent_app_type] => utility
[patent_app_number] => 11/218342
[patent_app_country] => US
[patent_app_date] => 2005-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15127
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073119.pdf
[firstpage_image] =>[orig_patent_app_number] => 11218342
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/218342 | Methods for treating neurodegenerative disorders | Aug 31, 2005 | Abandoned |